Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

Leukemia, 2009 - nature.com
Mantle cell lymphoma (MCL) accounts for 5–10% of all non-Hodgkin lymphomas and has
the worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) translocation …
被引用次数：39 相关文章

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin… - …, 2009 - pubmed.ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL) accounts for 5-10% of all non-Hodgkin lymphomas and has the
worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) translocation that …

[引用][C] Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

M WANG, L SUN, J QIAN, X HAN, L ZHANG, P LIN - Leukemia, 2009 - pascal-francis.inist.fr
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for
immunotherapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai… - Leukemia, 2009 - go.gale.com
Mantle cell lymphoma (MCL) accounts for 5-10% of all non-Hodgkin lymphomas and has the
worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) translocation that …

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

M Wang, L Sun, J Qian, X Han, L Zhang… - …, 2009 - mdanderson.elsevierpure.com
Mantle cell lymphoma (MCL) accounts for 5-10% of all non-Hodgkin lymphomas and has the
worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) translocation that …

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.

M Wang, L Sun, J Qian, X Han, L Zhang… - Leukemia …, 2009 - search.ebscohost.com
Mantle cell lymphoma (MCL) accounts for 5-10% of all non-Hodgkin lymphomas and has the
worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) translocation that …

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai… - Leukemia, 2009 - europepmc.org
Mantle cell lymphoma (MCL) accounts for 5% to 10% of all non-Hodgkin lymphomas and
has the worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) …
[HTML] nih.gov

[HTML][HTML] CYCLIN D1 AS A UNIVERSALLY-EXPRESSED MANTLE CELL LYMPHOMA-ASSOCIATED TUMOR ANTIGEN FOR IMMUNOTHERAPY

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai… - Leukemia, 2009 - ncbi.nlm.nih.gov
Mantle cell lymphoma (MCL) accounts for 5% to 10% of all non-Hodgkin lymphomas and
has the worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) …

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai… - Leukemia, 2009 - europepmc.org
Mantle cell lymphoma (MCL) accounts for 5% to 10% of all non-Hodgkin lymphomas and
has the worst prognosis among all lymphomas. The hallmark of MCL is at (11; 14) …

[引用][C] Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

M Wang, L Sun, J Qian, X Han, L Zhang, P Lin… - …, 2009 - Nature Publishing Group